Data as of Sep 19
| -0.71 / -3.10%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 16.50. The median estimate represents a -5.32% decrease from the last price of 22.18.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.